|
It was reported that the patient experienced return of pain with discomfort, soreness, and pinching, along with chest wall irritation following lead migration or dislodgement and stimulation in an undesired location.It was further reported that a device revision was performed in which both leads and the implantable pulse generator were replaced, and the leads were repositioned more midline to avoid chest wall irritation.The issue was reported as resolved, and the patient was reported alive with no injury.The manufacturer representative (rep) indicated they would send any further information as they become aware.
|
|
Other relevant device(s) are: product id: 977a260, serial/lot #: (b)(6), ubd: 21-jun-2027, udi#: (b)(4); product id: 9 77a260, serial/lot #: (b)(6), ubd: 28-sep-2027, udi#: (b)(4).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|